Latest Advances

  • Condition: Acute Myeloid Leukemia (AML)
  • Journal: Annals of hematology
  • Treatment Used: Decitabine
  • Number of Patients: 178
  • Published —
This study evaluated the outcomes of chromosome 17p loss or TP53 gene mutations in older, unfit patients with acute myeloid leukemia (AML) treated with decitabine (DAC).
  • Condition: Chronic Lymphocytic Leukemia
  • Journal: Leukemia research
  • Treatment Used: Ibrutinib
  • Number of Patients: 1729
  • Published —
The study researched the outcomes of ibrutinib in treating chronic lymphocytic leukemia.
  • Condition: Sleep in Children with Autism Spectrum Disorder
  • Journal: Journal of autism and developmental disorders
  • Treatment Used: Pediatric Prolonged-Release Melatonin
  • Number of Patients: 125
  • Published —
This study evaluated the effectiveness and safety of easily-swallowed prolonged-release melatonin mini-tablets (PedPRM; 2-5 mg) in improving sleep duration and onset in children aged 2-17.5 years with Autism Spectrum Disorder or Smith-Magenis syndrome and insomnia.
  • Condition: Self-injurious Behaviors in Children with Neurodevelopmental Disorders (NDDs)
  • Journal: Pharmacotherapy
  • Treatment Used: Behavior Therapies and Pharmocotherapy
  • Number of Patients: 0
  • Published —
This article discusses the management of self-injurious behaviors in children with neurodevelopmental (NDDs) disorders.
  • Condition: Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
  • Journal: Blood
  • Treatment Used: Duvelisib vs, Ofatumumab
  • Number of Patients: 319
  • Published —
This study compared duvelisib versus ofatumumab monotherapy for patients with relapsed or refractory (RR) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
  • Condition: Relapsed/refractory deletion 17p chronic lymphocytic leukaemia
  • Journal: British journal of haematology
  • Treatment Used: Ibrutinib
  • Number of Patients: 230
  • Published —
This study evaluated the clinical outcomes of patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia (CLL/SLL) from three studies which included Ibrutinib.
Showing 1-6 of 6